Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/01/1995 | EP0640341A1 Sustained release pharmaceutical composition and process for producing same |
03/01/1995 | EP0640340A1 Composition for accelerating healing of wound |
03/01/1995 | EP0640339A1 Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs |
03/01/1995 | EP0640338A1 Sodium cromoglycate for the treatment of upper respiratory tract infections |
03/01/1995 | EP0640143A1 Senescent cell derived inhibitors of dna synthesis |
03/01/1995 | EP0640088A1 Novel tricyclic thiazolo and thiazino derivatives and anti-viral medicaments containing them. |
03/01/1995 | EP0640087A1 Use of tricyclic pyrimidine derivatives as anti-viral medicaments |
03/01/1995 | EP0640086A1 NOVEL MERCAPTOACETYLAMIDO PYRIDAZO 1,2]PYRIDAZINE, PYRAZOLO 1,2]PYRIDAZINE, PYRIDAZO 1,2-a] 1,2]DIAZEPINE AND PYRAZOLO 1,2-a] 1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE |
03/01/1995 | EP0640085A1 Fused imidazole and triazole derivatives as 5-ht1 receptor agonists |
03/01/1995 | EP0640084A1 6-AMINO SUBSTITUTED IMIDAZO 4,5-b]PYRIDINES AS ANGIOTENSIN II ANTAGONISTS |
03/01/1995 | EP0640082A1 Heteroaromatic quinuclidinenes, their use and preparation |
03/01/1995 | EP0640081A1 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists |
03/01/1995 | EP0640078A1 Nitric 1,2-benzo-isothiazolyl-3(2h)one-1,1-dioxide esters, preparation method therefor and drugs containing same |
03/01/1995 | EP0640077A1 Oxazolidinones containing a substituted diazine moiety and their use as antimicrobials |
03/01/1995 | EP0640075A1 Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
03/01/1995 | EP0640074A1 Novel salts of a quinolone-carboxylic acid |
03/01/1995 | EP0640072A1 Substituted pyridines, their preparation and pharmaceutical use |
03/01/1995 | EP0640065A1 Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation |
03/01/1995 | EP0639986A1 Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents |
03/01/1995 | EP0639977A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities |
03/01/1995 | EP0639976A1 Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient |
03/01/1995 | EP0639975A1 Heterocyclic-substituted pyridine compounds and uses |
03/01/1995 | EP0639973A1 Diamines in the treatment of arrhythmia |
03/01/1995 | EP0639972A1 Method for preventing endothelium damage in mammals and for alleviating pain associated with gout and arthritis |
03/01/1995 | EP0639971A1 Therapeutic combinations |
03/01/1995 | EP0639970A1 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
03/01/1995 | EP0580753B1 Pyrimidine derivatives for enhancing antitumor activity |
03/01/1995 | EP0547090B1 Phenolic thioetheramides as 5-lipoxygenase inhibitors |
03/01/1995 | EP0502043B1 Utilization of xanthines, optionally incorporated in liposomes in order to help the pigmentation of skin or hair |
03/01/1995 | EP0486609B1 Pharmaceutical product for the treatment of sepsis |
03/01/1995 | EP0462264B1 Heterocyclic derivatives, method for preparing same, and their therapeutic applications as paf-antagonists |
03/01/1995 | EP0456833B1 Immunosuppressant and process for preparing the same |
03/01/1995 | EP0409910B1 Laminated composite for transdermal administration of fentanyl |
03/01/1995 | EP0406439B1 Diazabicycloalkane derivatives |
03/01/1995 | EP0406428B1 Peptide derivatives and their use |
03/01/1995 | EP0390911B1 Low-melting moldable pharmaceutical excipient and its use with pharmaceutical compositions |
03/01/1995 | CN1099394A Antiparasitic agents |
03/01/1995 | CN1099392A Compounds containing a fused bicyclic ring and processes therefor |
03/01/1995 | CN1099391A Benzimidazole compounds, their use and preparation |
03/01/1995 | CN1099386A 1,2,5,6-tetrahydropyridine derivative, process for preparing it and its applications in therapy |
03/01/1995 | CN1099380A Alicyclic phospholipase A2 inhibitors |
03/01/1995 | CN1099268A Process for production of amino acid oral liquid |
03/01/1995 | CN1099266A Preparation of hypolipemic from half ester of oleanolic succinic acid |
03/01/1995 | CN1099265A Composition for accelerating healing of wound |
03/01/1995 | CN1099264A Cell differentiation inducer comprising acyclic polyisoprenoid |
03/01/1995 | CN1099263A Ipsapirone medicament formulation |
03/01/1995 | CN1099262A Controlled release formulation |
03/01/1995 | CN1027759C Novel acetylcholinesterase inhibitors |
03/01/1995 | CA2131116A1 Composition for rectal administration |
03/01/1995 | CA2130971A1 Sulfonamide endothelin antagonists |
03/01/1995 | CA2117600A1 2-(1h)-quinolinone derivatives; process for preparing the same and pharmaceutical compositions containing them |
02/28/1995 | US5393900 Steroid intermediates for the formation of vitamin D3 analogues |
02/28/1995 | US5393897 Isolation and structure of spongistatins 5,7,8 and 9 |
02/28/1995 | US5393896 Treating ground yew parts with water, separating aqueous solution, extracting with organic solvent, desolventizing, crystallizing, isolating |
02/28/1995 | US5393889 Water soluble bis-dioxopiperazine derivatives |
02/28/1995 | US5393883 Ribonucleotide reductase inhibitors |
02/28/1995 | US5393878 Pyrimidine nucleosides having cyclopentafuran skeleton |
02/28/1995 | US5393875 Amino acid derivatives having renin inhibiting activity |
02/28/1995 | US5393792 High dosage topical forms of collagenase |
02/28/1995 | US5393788 Administering in the treatment of asthma or an allergic or inflammatory disease |
02/28/1995 | US5393786 Administering certain phenolic compounds |
02/28/1995 | US5393785 Therapeutic antiestrogens |
02/28/1995 | US5393784 Treatment of tardive dyskinesia with leucine, isoleucine, valine or mixtures thereof |
02/28/1995 | US5393779 Anti-obesity, hypoglycemic, adrenergic blocking agents |
02/28/1995 | US5393777 Deferration using anguibactin siderophore |
02/28/1995 | US5393775 Benzopyran compounds |
02/28/1995 | US5393774 Phenylethanolamines, pharmaceutical compositions containing these compounds and process for preparing them |
02/28/1995 | US5393773 Method for the intranasal administration of 3-[2-(dimethylamino)-ethyl]-H-methyl-1H-indole-5-methanesulphonamide |
02/28/1995 | US5393772 Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation |
02/28/1995 | US5393771 4-substituted benzopyran and related compounds |
02/28/1995 | US5393768 Treating hypersensitivity reactions such as asthma |
02/28/1995 | US5393765 Pharmaceutical compositions with constant erosion volume for zero order controlled release |
02/28/1995 | US5393763 Methods for inhibiting bone loss |
02/28/1995 | US5393762 Pharmaceutical agents for treatment of emesis |
02/28/1995 | US5393761 Treatment of nervous system disorders |
02/28/1995 | US5393760 Guanidine derivatives |
02/28/1995 | US5393758 Substituted azetidinylpyridone naphthyridine carboxylic acid derivatives and their application as medical products |
02/28/1995 | US5393757 Polyamines and anti-diarrheal and gastrointestinal anti-spasmodic pharmaceutical compositions and methods of treatment |
02/28/1995 | US5393755 Polycyclic guanine derivatives |
02/28/1995 | US5393753 Substituted imidazobenzazepines |
02/28/1995 | US5393751 Antibiotics |
02/28/1995 | US5393749 Method of treating osteoporosis with 1 α25-dihydroxy-22(E)-dehydro-vitamin D3 |
02/28/1995 | US5393748 Methylenebisphosphonic acid derivatives |
02/28/1995 | US5393747 Substituted dibenzoxazepine compounds for the treatment of convulsions, ischemia and other diseases responsive to prostaglandin-E2 antagonists |
02/28/1995 | US5393745 Method for treating aphthae using dimethylpolysiloxane |
02/28/1995 | US5393743 Erythromycin derivatives |
02/28/1995 | US5393742 Preparation for treating renal disease |
02/28/1995 | US5393741 Anticarcinogenic agents |
02/28/1995 | US5393737 Cytotoxic drug conjugates for treatment of neoplastic diseases |
02/28/1995 | US5393729 Pesticides, fungicides, herbicides |
02/28/1995 | US5393535 Water in oil emulsion |
02/28/1995 | US5393529 Sustained release |
02/28/1995 | US5393513 Stable, highly concentrated fluoro carbon emulsions |
02/28/1995 | US5392767 Atomizing a solution of furosemide |
02/28/1995 | US5392725 Sewing machine needle and method for manufacturing same |
02/28/1995 | CA2130015A1 Preparation of a skin surface for a surgical procedure |
02/28/1995 | CA2028560C Methods and compositions employing certain lysozymes and endoglycosidases |
02/28/1995 | CA1334592C Pyridinyl-quinolone compounds, their preparation and use |
02/28/1995 | CA1334591C 1,4-dihydropyridine carboxylic acid ester derivatives, processes for their preparation and pharmaceutical compositions containing same |
02/28/1995 | CA1334589C Benzodiazepine derivatives |